Evaluation of Planned Conservative Surgical Management of Placenta Accreta Spectrum in Women's Health Center, Assiut University Hospital
1 other identifier
observational
150
0 countries
N/A
Brief Summary
In recent years, with the application of an abdominal artery balloon and the improvement of surgical techniques, efforts are made to preserve the uterus for patients PAS. the aim of the study To evaluate conservative surgical management of placenta accreta spectrum in Assiut University hospital regarding maternal and fetal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedDecember 2, 2024
November 1, 2024
1 year
November 27, 2024
November 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
amount of blood loss
amount of blood loss during operation according to number of towels and amount of blood in suction pump
baseline
Study Arms (1)
patients with placenta accrete spectrum
patients with placenta accrete spectrum secondary to previous cesarean section will be recruited from the outpatient clinic and reception unit, Assiut, Egypt.
Eligibility Criteria
patients with placenta accrete spectrum secondary to previous cesarean section and Gestational age above 28 weeks
You may qualify if:
- Pregnant women with history of previous caesarean section.
- Age above 18 years.
- Gestational age above 28 weeks.
- U/S signs suggestive of placenta previa accreta.
- Confirmed diagnosis of Placenta previa accreta spectrum disorder by 3 D U/S, Doppler or MRI if needed.
You may not qualify if:
- Gestational age less 28 weeks.
- Age less than 18 years.
- Patients with known bleeding disorders.
- Multiple pregnancy.
- Other pathology (fibroid, ………………..).
- Patients with placental separation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Cali G, Forlani F, Giambanco L, Amico ML, Vallone M, Puccio G, Alio L. Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta. Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:36-41. doi: 10.1016/j.ejogrb.2014.05.007. Epub 2014 May 21.
PMID: 24965977RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor Obsetitric and Gynacology
Study Record Dates
First Submitted
November 27, 2024
First Posted
December 2, 2024
Study Start
January 1, 2025
Primary Completion
January 1, 2026
Study Completion
February 1, 2026
Last Updated
December 2, 2024
Record last verified: 2024-11